Back to Search
Start Over
Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic.
- Source :
-
NPJ vaccines [NPJ Vaccines] 2020 Jul 06; Vol. 5, pp. 58. Date of Electronic Publication: 2020 Jul 06 (Print Publication: 2020). - Publication Year :
- 2020
-
Abstract
- Convalescent plasma therapy holds promise as a transient treatment for COVID-19. Yet, blood products are important sources of HIV infection in low- and middle-income nations. Great care must be taken to prevent plasma therapy from fueling HIV epidemics in the developing world.<br />Competing Interests: Competing interestsL.M.R.F. holds patents on cell-based gene therapy methods for HIV treatment. M.A.M.-R. is the Bolivian Science, Technology and Innovation Ambassador and leads the Bolivian COVID-19 response team. The authors declare no other conflict of interest.<br /> (© The Author(s) 2020.)
Details
- Language :
- English
- ISSN :
- 2059-0105
- Volume :
- 5
- Database :
- MEDLINE
- Journal :
- NPJ vaccines
- Publication Type :
- Academic Journal
- Accession number :
- 32655899
- Full Text :
- https://doi.org/10.1038/s41541-020-0209-2